Irrespective of US corporate-tax rates and other changes, medical-device companies should come out ahead under the Trump administration since the 2.3% ObamaCare excise tax on medical devices (which is not tax-deductible) is likely to be permanently killed.
Wait, are you saying the companies are not going to pass the savings to the customer?!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.